Moreover, we determined how downregulation of CHIP regulates OCT4 expression in CSCs and in breast tumorigenesis, and whether regulation of OCT4 stability is a reasonable approach for breast cancer therapy. This evidence concerns the gene POU5F1 and breast cancer.